The Protein Diagnostics Market is witnessing steady growth as healthcare providers increasingly adopt advanced diagnostic technologies for accurate disease detection and patient management. The market was valued at approximately USD 8.9 billion in 2024 and is projected to reach USD 15 billion by 2035, expanding at a CAGR of around 4.9% during the forecast period.

The increasing prevalence of chronic diseases, growing demand for personalized medicine, and technological advancements in protein analysis are major factors supporting market development. Protein diagnostics play an important role in identifying biomarkers associated with diseases and supporting early diagnosis, treatment monitoring, and therapeutic decision-making.

The market is segmented by application, technology, end use, and region. Major applications include clinical diagnostics, drug discovery, personalized medicine, and research and development. Technologies include mass spectrometry, electrophoresis, immunoassays, Western blotting, and protein microarrays.

North America currently represents a leading regional market because of its advanced healthcare infrastructure and strong investment in research and development. Meanwhile, Asia-Pacific is expected to experience significant growth as healthcare access, diagnostic awareness, and medical technology adoption increase.

The integration of artificial intelligence, automation, point-of-care testing, and advanced bioinformatics is creating additional opportunities. Overall, continued innovation and rising demand for accurate diagnostic solutions are expected to support the long-term expansion of the Protein Diagnostics Market.